O15530 (PDPK1_HUMAN) Homo sapiens (Human)

3-phosphoinositide-dependent protein kinase 1 UniProtKBInterProSTRINGInteractive Modelling

556 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3; Isoform 4; Isoform 5)

Available Structures

70 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Crystal structure of PDK1 in complex with ATP and PIFtide Heteromer
Q16513;
76-359
ATP;GOL;
Assess
Crystal structure of WDR5 in complex with the WIN peptide of PDPK1 Heteromer
P61964;
2-11
Assess
High resolution crystal structure of the human PDK1 catalytic domainhomo-2-mer71-359
16×GOL; 10×SO4;ATP;
Assess
Crystal structure of PDK1 in complex with a pyrazoloquinazoline inhibitorhomo-2-mer73-359
CKG; 12×GOL; 12×SO4;
Assess
Crystal structure of PDK1 in complex with a pyrazoloquinazoline inhibitorhomo-2-mer76-359
MH4;GOL;SO4;
Assess
Human PDK1 Kinase Domain in Complex with Allosteric Compound PS210 Bound to the PIF-Pocketmonomer66-359
ATP;21O;DMS;MN;NA;CL;
Assess
Human PDK1 kinase domain in complex with Valsartanmonomer70-359
U35;GOL;
Assess
Crystal structure of PDK1 in complex with ATP and the PIF-pocket ligand RF4monomer71-359
ATP;RF4;GOL;
Assess
Crystal structure of PDK1 in complex with ATP and the PIF-pocket ligand RS2monomer71-359
GOL;ATP;R2S;
Assess
Structure of human PDK1 kinase domain in complex with staurosporinemonomer72-360
GOL;SO4;STU;
Assess
Structure of human PDK1 kinase domain in complex with BIM-8monomer71-359
GOL;SO4;BI8;
Assess
DISCOVERY OF NOVEL 7-AZAINDOLES AS PDK1 INHIBITORSmonomer71-359
63L;SO4;
Assess
DISCOVERY OF NOVEL 7-AZAINDOLES AS PDK1 INHIBITORSmonomer71-359
SO4;62O;
Assess
Crystal structure of an extender (SPD28345)-modified human PDK1 complex 2monomer71-359
SYP;
Assess
Structure of human PDK1 kinase domain in complex with LY333531monomer73-360
GOL;SO4;LY4;
Assess
Structure of PDK1-S241A mutant kinase domainmonomer72-359
GOL;SO4;ATP;
Assess
Phosphoinositide-Dependent Kinase-1 (PDK1) kinase domain with 1,1-Dimethylethyl {(3R,6S)-1-[2-amino…monomer71-358
3Q5;SO4;GOL;
Assess
phosphoinositide-dependent kinase-1 (PDK1) with lead compoundmonomer71-358
GOL;SO4;JMZ;
Assess
Phosphoinositide-Dependent Kinase-1 (PDK1) kinase domain with 1,1-Dimethylethyl{(3R,5R)-1-[2-amino-…monomer71-358
3Q6;SO4;
Assess
Discovery of a Novel, Potent and Selective Inhibitor of 3-Phosphoinositide Dependent Kinase (PDK1)monomer72-359
3RW;GOL;SO4;
Assess
DISCOVERY OF NOVEL 7-AZAINDOLES AS PDK1 INHIBITORSmonomer71-358
63E;SO4;
Assess
Human PDK1 Kinase Domain in Complex with Allosteric Compound PSE10 Bound to the PIF-Pocketmonomer73-359
ATP;78W;DMS;DTD;CL;
Assess
Human PDK1 Kinase Domain in Complex with Allosteric Compound 7 Bound to the PIF-Pocketmonomer73-359
ATP;SVQ;DTD;DMS;NA;
Assess
Structure of human PDK1 kinase domain in complex with BIM-2monomer73-359
GOL;BI2;SO4;
Assess
Discovery of a Novel, Potent and Selective Inhibitor of 3-Phosphoinositide Dependent Kinase (PDK1)monomer73-359
GOL;SO4;ABQ;
Assess
Structure of human PDK1 kinase domain in complex with BIM-1monomer72-358
GOL;SO4;BI1;
Assess
Structure of human PDK1 kinase domain in complex with UCN-01monomer73-359
GOL;SO4;UCN;
Assess
PDK1 in complex with inhibitor MP6monomer76-362
MP6;
Assess
Novel Isoquinolone PDK1 Inhibitors Discovered through Fragment-Based Lead Discoverymonomer73-359
3S1;SO4;GOL;
Assess
Human PDK1 Kinase Domain in Complex with Compound PS653 Bound to the ATP-Binding Sitemonomer74-359
537;DTD;DMS;
Assess
Crystal structure of PDK1 in complex with ATP and the PIF-pocket ligand RS1monomer74-359
GOL;ATP;R1S;EPE;
Assess
Structure of human PDK1 kinase domain in complex with BIM-3monomer72-357
GOL;SO4;BI3;
Assess
phosphoinositide-dependent kinase-1 (PDK1) with fragment11monomer73-358
GOL; 10×SO4;JOZ;
Assess
Phosphoinositide-Dependent Kinase-1 (PDK1) kinase domain with (2R,5S)-1-[2-Amino-6-(3-amino-1H-inda…monomer73-358
GOL;SO4;3Q4;
Assess
PDK1 mutant bound to allosteric disulfide fragment activator 2A2monomer74-359
2A2;BI4;
Assess
phosphoinositide-dependent kinase-1 (PDK1) with fragment17monomer73-358
GOL;SO4;JPZ;
Assess
CRYSTAL STRUCTURE OF HUMAN PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1 (PDK1) 3-{5-[2-Oxo-5-ureido-…monomer74-359
SO4;464;GOL;
Assess
CRYSTAL STRUCTURE OF HUMAN PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1 (PDK1) {2-Oxo-3-[1-(1H-pyrro…monomer74-359
SO4;517;GOL;
Assess
Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl)amino]phenyl]amino]-4-pyrimidin…monomer74-359
SO4;CL;LI8;GOL;
Assess
Phosphoinositide-Dependent Kinase-1 (PDK1) kinase domain with 4-[2-Amino-6-(3-amino-1H-indazol-6-yl…monomer73-358
GOL;SO4;3Q3;
Assess
Phosphoinositide-Dependent Kinase-1 (PDK1) kinase domain with 6-{2-Amino-6-[(3R)-3-methyl-4-morphol…monomer73-358
GOL;SO4;3Q2;
Assess
CRYSTAL STRUCTURE OF HUMAN PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1 (PDK1) 5-Hydroxy-3-[1-(1H-py…monomer74-359
SO4;39Z;GOL;
Assess
Phosphoinositide-Dependent Kinase-1 (PDK1) kinase domain with 6-[2-Amino-6-(4-morpholinyl)-4-pyrimi…monomer73-358
GOL;SO4;3Q1;
Assess
Phosphoinositide-Dependent Kinase-1 (PDK1) kinase domain with 6-(3-Amino-1H-indazol-6-yl)-N4-ethyl-…monomer73-358
GOL;SO4;3Q0;
Assess
phosphoinositide-dependent kinase-1 (PDK1) with fragment8monomer73-358
GOL;JNZ;SO4;
Assess
Human PDK1-PKCzeta Kinase Chimeramonomer75-359
ATP;DTD;NA;
Assess
Human PDK1 Kinase Domain in Complex with Adenosine Bound to the ATP-Binding Sitemonomer75-359
DTD;ADN;CL;
Assess
Human PDK1 Kinase Domain in Complex with Allosteric Compound PS182 Bound to the PIF-Pocketmonomer75-359
ATP;MJF;DMS;MG;DTD;
Assess
PDK1 in complex with inhibitor MP7monomer76-360
MP7;
Assess
Human PDK1 Kinase Domain in Complex with Allosteric Activator PS171 Bound to the PIF-Pocketmonomer75-359
ATP;AZ7;MG;CL;
Assess
Crystal structure of Human PDK1 kinase domain in complex with an allosteric activator bound to the …monomer75-359
ATP;P47;EPE;
Assess
Human PDK1 Kinase Domain in Complex with Allosteric Activator PS114 Bound to the PIF-Pocketmonomer75-359
ATP;A06;DMS;CL;
Assess
PDK-1 in complex with the inhibitor Compound-8imonomer75-359
8I1;
Assess
PDK1 mutant bound to allosteric disulfide fragment inhibitor 1F8monomer75-359
1F8;CL;
Assess
Phosphoinositide-dependent protein kinase 1 (PDK-1) in complex with compound 9monomer75-359
9BD;
Assess
PDK1 in complex with Compound 8hmonomer75-359
8H1;SO4;
Assess
Human PDK1 Kinase Domain in Complex with an HM-Peptide Bound to the PIF-Pocketmonomer75-359
ATP;
Assess
Crystal Structure of the Phosphoinositide-dependent Kinase-1 (PDK-1)Catalytic Domain bound to a dib…monomer75-359
SO4;253;
Assess
Human PDK1 Kinase Domain in Complex with Adenine Bound to the ATP-Binding Sitemonomer76-359
ADE;DTD;
Assess
Human PDK1-PKCiota Kinase Chimera in Complex with Allosteric Compound PS267 Bound to the PIF-Pocketmonomer76-359
S26;DTT;DMS;ATP;
Assess
PDK1 in complex with DFG-OUT inhibitor xxxmonomer76-359
MP7;
Assess
Human PDK1-PKCzeta Kinase Chimera in Complex with Allosteric Compound PS315 Bound to the PIF-Pocketmonomer76-359
ATP;31S;DMS;DTD;
Assess
Crystal structure of a mutant of human PDK1 Kinase domain in complex with ATPmonomer76-359
ATP;
Assess
DISCOVERY OF NOVEL 7-AZAINDOLES AS PDK1 INHIBITORSmonomer76-358
SO4;61Y;
Assess
PDK1 mutant bound to allosteric disulfide fragment activator JS30monomer77-359
J30;BI4;SO4;CL;
Assess
Rapid preparation of triazolyl substituted NH-heterocyclic kinase inhibitors via one-pot Sonogashir…monomer77-358
3RC;
Assess
Crystal Structure of the PDK1 Pleckstrin Homology (PH) domainmonomer410-556
GOL;SO4;
Assess
Crystal Structure of the PDK1 Pleckstrin Homology (PH) domain bound to DiC4-phosphatidylinositol (3…monomer409-550
4PT;
Assess
Crystal Structure of the PDK1 Pleckstrin Homology (PH) domain bound to Inositol (1,3,4,5)-tetrakisp…monomer409-550
GOL;AU;4IP;
Assess
Structure of the PDK1 PH domain K465E mutantmonomer410-549
GOL;SO4;
Assess

2 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
3rwq.1.Amonomer0.8572-359
3RW;100.00
Assess
4mvf.1.Amonomer0.5470-423
33.15
Assess

8 SWISS-MODEL models built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 22biy.1.Amonomer0.8622-308
ATP;99.68
Assess
Isoform 24mvf.1.Amonomer0.5420-373
33.24
Assess
Isoform 33qd3.1.Amonomer0.8471-332
3Q5;100.00
Assess
Isoform 34mvf.1.Amonomer0.5670-397
32.84
Assess
Isoform 41w1h.2.Amonomer0.82282-429
100.00
Assess
Isoform 43rwq.1.Amonomer0.7178-232
81.94
Assess
Isoform 52biy.1.Amonomer0.8772-358
ATP;99.68
Assess
Isoform 54mvf.1.Amonomer0.5370-423
33.15
Assess